Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,388 | -5,698 | -4,342 | -2,801 | -1,550 |
| Depreciation Amortization | 1 | 1 | 1 | 0 | 2 |
| Accounts payable and accrued liabilities | -148 | -408 | -228 | -280 | 552 |
| Other Working Capital | 1,018 | -43 | -859 | -1,138 | 1,480 |
| Other Operating Activity | 3,058 | 3,238 | 2,688 | 2,449 | -1,434 |
| Operating Cash Flow | $-4,459 | $-2,911 | $-2,741 | $-1,769 | $-950 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -20 | -20 | -20 | -20 | 0 |
| Investing Cash Flow | $-20 | $-20 | $-20 | $-20 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,756 |
| Common Stock Issued | 14,101 | 14,101 | 4,100 | 4,114 | N/A |
| Other Financing Activity | -1,485 | -1,493 | -311 | -257 | -1,146 |
| Financing Cash Flow | $12,616 | $12,608 | $3,788 | $3,857 | $610 |
| Exchange Rate Effect | 90 | 75 | 80 | 50 | 3 |
| Beginning Cash Position | 167 | 167 | 167 | 167 | 500 |
| End Cash Position | 8,394 | 9,919 | 1,274 | 2,285 | 160 |
| Net Cash Flow | $8,227 | $9,752 | $1,107 | $2,118 | $-330 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,459 | -2,911 | -2,741 | -1,769 | -950 |
| Free Cash Flow | -4,459 | -2,911 | -2,741 | -1,769 | -950 |